S.2983: ADAPT for COVID Act

About This Bill

Bill Sponsor

Bill Version

Bill Summary

Accelerated Drug Approval for Prescription Therapies for Coronavirus Act or the ADAPT for COVID Act This bill authorizes the Food and Drug Administration (FDA)to create an expedited drug approval process specifically for drugs that are currently approved for sale in certain countries (i.e., a European Economic Area member country, Australia, Canada, Israel, Japan, New Zealand, South Africa, or Switzerland) and meet certain criteria. Such...

(Source: Library of Congress)

What Lawmakers Are Saying About This Bill

There is one statement associated with S.2983.

Bill Actions

Date Description
Oct. 7, 2021
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Oct. 7, 2021

Introduced in the Senate by Mike Braun (R-Ind.)

Close Comment Creative Commons Donate Email Facebook Mobile Phone Podcast Print Google News logo Google_NewsInitiative_Lockup_FullColor RSS Search Search Twitter WhatsApp Resolving differences Check Building Arrow right Info circle Oops OOPS Pencil File text Bars Search Close Cogs Filter Compare Revolving Door Info card Activity Member menu Globe Document External link Quote News Calendar No Vote
Current site Current page